Valves are described for intravenous (IV) catheter assemblies for controlling fluidic flow. The valve can prevent blood leakage in multiple access use situations. A thinner area of the valve around a slit is provided. The thicker area of the valve is to provide rigidity to the valve so that it is able to return to a closed configuration when a Luer connector is removed.

A transcranial fastening device (1) for a drainage catheter (3), comprising an external body (5) being equipped with a passage (P), the passage (P) being equipped with blocking means (9) of the drainage catheter (3) adapted to allow a sliding of the drainage catheter (3) through the passage (P) along a first movement direction (M1) and to prevent a sliding of the drainage catheter (3) through the passage (P) along a second movement direction (M2).

A medical valve can include a housing that includes a sidewall and defines a chamber. The medical valve can include a septum coupled to the housing. The septum can include a proximal surface and a selectively openable closure positioned within the chamber. The medical valve can further include a plurality of projections that extend away from the sidewall and are configured to contact the proximal surface of the septum to oppose movement of a restricted portion of the septum in a proximal direction such that an aspiration cracking pressure required to open the closure to permit fluid flow through the septum in the proximal direction exceeds an infusion cracking pressure required to open the closure to permit fluid flow through the septum in the distal direction.

A multi-catheter infusion system and method for the localized delivery of medications while minimally affecting patient mobility for an extended period of time. The multi-catheter infusion system includes a cannula and a plurality of catheters. The cannula includes a first end for connecting to a drug delivery system and a second end for connecting to the plurality of catheters. The plurality of catheters are in fluid communication with the cannula for delivering a drug to a target area of a patient. Each catheter includes a multi-orifice distal end.

Fluid communication devices and supporting structures may be provided for use with intraosseous devices. Apparatus and methods may also be provided to communicate fluids with an intraosseous device.

A port is adapted to be implanted to a body with its top exposed to the environment. The port has a housing defining a chamber that has an opening at the top of the housing. An aperture having a lumen attached thereto is formed at the lower portion of the chamber. For infusion, an insert that has an internal passageway that connects a fluid inlet at its top surface and a bore at its sidewall is sealingly mated to the chamber. The bore sealingly aligns with the aperture. After infusion, the insert is removed, and a blank insert is fitted to the chamber. A band of tissue ingrowth media encircles the housing to form an aseptic barrier where the outer wall of the housing and the tissue of the body encircling the housing meet.

A medical device material impregnated with a combination of antimicrobial agents, the combination of antimicrobial agents comprising a first antimicrobial agent, the first antimicrobial agent being triclosan and at least a second antimicrobial agent, wherein the combination of antimicrobial agents provides the device material with antimicrobial activity and inhibition of resistant microbial mutations for of the order of, or greater than, 80 days.

A cover for a percutaneous connector extending through the skin of a patient. The cover includes a structure having an inner side and an outer side. A first separable connector is mounted to the structure and disposed entirely within the structure, the first separable connector being configured to detachably engage and electrically connect with the percutaneous connector. A second separable connector is mounted to the structure and electrically connected to the first separable connector, the second separable connector being exposed at the outer side of the structure and being configured to detachably engage and electrically connect with an external device. The inner side of the structure defines a skin-engaging surface at least partially surrounding the first separable connector and the percutaneous connector, when the first separable connector is engaged with the percutaneous connector.

An antimicrobial medical device for use during the placement of a catheter. The antimicrobial medical device includes a tubular body configured to receive the catheter through a lumen of the tubular body during an intravascular procedure and wall of the tubular body forms a liner between catheter and the patient's skin. The device further includes an antimicrobial material coupled with the tubular body so that in use the antimicrobial material inhibits microbe growth at the insertion site.

A therapeutic delivery device that provides a controlled release of high doses of a therapeutic agent in a local area, sustains the high dose controlled release with a percutaneous port for refilling the device, and is versatile for use with multiple types of therapeutic agents and/or implant systems. A rate determining/controlled release membrane is used to decrease the molecular mobility of the therapeutic compounds thereby controlling the therapeutic release profile. The therapeutic delivery device includes a body defining an internal reservoir for receiving a therapeutic agent and including a first membrane for providing a controlled release of the therapeutic agent to the surgical site, a port in fluid communication with the reservoir, a sleeve configured to encapsulate the body, and a rigid housing configured to support the body and a portion of the sleeve, the rigid housing configured to release the body and the sleeve after the body and the sleeve are anchored position relative to the surgical site.